Piddybull. schreef op 1 juni 2022 12:58:
Tadmak /Discord
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Arrowhead Pharmaceuticals (ARWR – Research Report), with a price target of
$100.00. The company’s shares closed last Tuesday at
$33.33, close to its 52-week low of $27.87.\